LLY250103C800000
- 0.05
- 0.000.00%
Eli Lilly and Co Newsroom
FDA Issues Draft Guidance on Developing Weight Loss Drugs
Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Eli Lilly's Options: A Look at What the Big Money Is Thinking
Express News | Refile-Buzz-Obesity Drugs, M&a Among Key Pharma Drivers for 2025, Berenberg Says
Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,146
Express News | Remedium Lifecare - Calls Media Reports Claiming Co Got Order From Eli Lilly Speculative, Unfounded
Lilly to Participate in J.P. Morgan Healthcare Conference
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Is Eli Lilly and Company (NYSE:LLY) Among Israel Englander's Top Stock Picks Heading Into 2025?
J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,100
Express News | Orbis Medicines: Financing Led by Nea With Participation From Eli Lilly, Export and Investment Fund of Denmark, Novo Holdings, Forbion, Others
Israel Englander's Millennium Management Dumps Nvidia, Loads Up On Broadcom — Here's What The $70 Billion Hedge Fund Sees
Eli Lilly's (NYSE:LLY) Dividend Will Be Increased To $1.50
Novo Nordisk Seeks to Block Compounded Victoza
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz